查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1939331

2026年全球膽紅素血液檢測市場報告

Bilirubin Blood Test Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，膽紅素血液檢測市場成長顯著，預計到2025年將達到14.6億美元，到2026年將達到15.7億美元，複合年成長率為7.4%。過去幾年的成長可歸因於以下因素：新生兒黃疸篩檢計畫的增加、醫院肝功能檢測的普及、肝病診斷意識的提高、血清膽紅素檢測在常規臨床實踐中的應用，以及兒童和嬰兒診斷服務的擴展。

預計未來幾年，膽紅素血液檢測市場將維持強勁成長，2030年市場規模將達到20.8億美元，複合年成長率（CAGR）為7.3%。預測期內的成長要素包括慢性肝病和肝炎負擔日益加重、對早期肝功能評估的需求不斷成長、基層醫療機構中膽紅素檢測的使用率不斷提高、老年人和高風險人群的檢測率不斷上升，以及就地檢驗和肝臟專科診斷的普及。預測期內的主要趨勢包括：膽紅素檢測在肝功能評估中的應用日益廣泛、新生兒黃疸篩檢中膽紅素檢測的普及率不斷提高、血液學和肝病早期評估中對檢測的需求不斷成長、醫院和臨床機構中膽紅素監測的普及，以及對肝臟健康早期發現和常規篩檢的重視。

預計未來幾年，肝病發生率的不斷上升將推動膽紅素血液檢測市場的成長。肝病是指各種損害正常肝功能的病理狀況，其原因包括感染疾病、過量飲酒和代謝紊亂等。肝病病例的增加主要與導致肝損傷和功能障礙的因素有關，例如肥胖率上升、大量飲酒、病毒感染和不健康的生活方式。肝病會顯著影響體內膽紅素水平，而膽紅素血液檢測用於診斷和監測肝功能，提供有關患者健康狀況的重要資訊，並幫助醫療專業人員有效管理和治療肝臟相關疾病。例如，根據英國科學技術部（GOV.UK）截至2023年4月的數據，肝病住院率將從2022會計年度的每10萬人150.6例（148.2-152.9例）上升至2023會計年度的每10萬人155.2例（152.9例）上升至2023會計年度的每10萬人155.2例（152.9-157.5例住院人數持續，顯示肝病。因此，肝病發生率的上升正在推動膽紅素血液檢測市場的成長。

膽紅素血液檢測市場的主要企業正在加強策略聯盟，以擴大業務範圍並改善產品和服務。策略聯盟是一種合作關係，其中兩個組織匯集資源和專業知識，以實現共同目標。例如，2023年12月，總部位於以色列的醫療診斷生物技術公司Calmark Sweden AB與沙烏地阿拉伯的Techno Orbits公司簽署了一項獨家經銷協議，將負責Calmark新生兒膽紅素檢測套組的分銷和銷售。 Techno Orbits將利用其現有的網路和關係（包括與沙烏地阿拉伯衛生署）來管理Calmark產品的分銷和銷售。此次合作旨在將Calmark的膽紅素檢測產品引入沙烏地阿拉伯市場，預計監管註冊需要三到六個月的時間。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球膽紅素血液檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 膽紅素檢測在評估肝功能的應用日益廣泛
    • 擴大膽紅素檢測在新生兒黃疸篩檢的應用
    • 血液學和肝前疾病評估中檢測需求不斷成長
    • 在醫院和臨床機構擴大膽紅素監測
    • 重視肝臟健康的早期發現和定期篩檢

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 診斷檢查室
  • 兒童和新生兒醫療中心
  • 肝臟及消化系統專科中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球膽紅素血液檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球膽紅素血液檢測市場規模、對比及成長率分析
  • 全球膽紅素血液檢測市場表現：規模與成長，2020-2025年
  • 全球膽紅素血液檢測市場預測：規模與成長，2025-2030年，2035年

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按測試類型
  • 總血清膽紅素試驗、間接（非結合）膽紅素試驗、直接（結合）膽紅素試驗
  • 按年齡層
  • 成人、兒童和嬰兒
  • 透過使用
  • 醫院、診所和其他用途
  • 按類型細分：總血清膽紅素檢測
  • 常規篩檢、肝功能評估和新生兒黃疸檢測
  • 按類型細分：間接膽紅素（非結合膽紅素）檢測
  • 溶血性貧血的診斷、吉伯特症候群的檢測、肝前狀態的監測
  • 按類型細分：直接膽紅素（結合膽紅素）檢測
  • 膽管阻塞的診斷、肝炎和肝病的後續觀察、肝病後狀態的評估

第10章 區域與國家分析

  • 全球膽紅素血液檢測市場：依地區、績效及預測分類，2020-2025年、2025-2030年、2035年
  • 全球膽紅素血液檢測市場：依國家/地區、績效及預測分類，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 膽紅素血液檢測市場：競爭格局及市場佔有率（2024年）
  • 膽紅素血液檢測市場：公司估值矩陣
  • 膽紅素血液檢測市場：公司概況
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • Danaher Corporation

第37章：其他領先和創新企業

  • Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMerieux SA, DiaSorin SpA, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年膽紅素血液檢測市場：提供新機會的國家
  • 2030年膽紅素血液檢測市場：新興細分市場機會
  • 2030年膽紅素血液檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MBBTL01_G26Q1

The bilirubin blood test is a diagnostic procedure used to measure bilirubin levels in the blood. This test is important for evaluating liver function and diagnosing conditions such as jaundice and liver disease. It is crucial for assessing bilirubin metabolism and identifying liver health issues.

The main types of bilirubin blood tests includes the total serum bilirubin test, the indirect or unconjugated bilirubin test, and the direct or conjugated bilirubin test. The total serum bilirubin test measures the combined amount of unconjugated (indirect) and conjugated (direct) bilirubin in the blood. This test is essential for assessing overall liver health and diagnosing various liver-related conditions. The test is applicable to adults, pediatrics, and infants, and it is used in hospitals, clinics, and other healthcare settings.

Tariffs are affecting the bilirubin blood test market by increasing the costs of diagnostic analyzers, reagent kits, assay consumables, and laboratory instrumentation components that depend on cross-border supply chains, leading to higher procurement and testing costs. The impact is most evident across hospitals and clinical laboratories, especially in regions such as Asia-Pacific and Europe where reagent imports and analyzer components are tariff sensitive. Pediatric, infant, and adult testing segments are experiencing cost pressures and slower equipment upgrade cycles due to tariff-driven price pass-throughs. At the same time, tariffs are encouraging localized reagent manufacturing, regional analyzer assembly, and domestic supply chain development, which may strengthen long-term production resilience and market stability.

The bilirubin blood test market research report is one of a series of new reports from The Business Research Company that provides bilirubin blood test market statistics, including bilirubin blood test industry global market size, regional shares, competitors with a bilirubin blood test market share, detailed bilirubin blood test market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin blood test industry. This bilirubin blood test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.46 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rise in neonatal jaundice screening programs, increasing hospital-based liver function testing, growth in diagnostic awareness of liver disorders, adoption of serum bilirubin testing in routine clinical practice, expansion of pediatric and infant diagnostic services.

The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growing burden of chronic liver disease and hepatitis, rising demand for early liver health assessment, increasing utilization of bilirubin testing in primary care settings, higher testing rates in aging and at-risk patient populations, expansion of point-of-care and specialty liver diagnostics. Major trends in the forecast period include increasing use of bilirubin testing for liver function assessment, growing adoption of bilirubin tests in neonatal jaundice screening, rising testing demand in hematology and preliver disorder evaluation, expansion of bilirubin monitoring across hospital and clinical settings, focus on early detection and routine screening for liver health.

The increasing incidence of liver diseases is expected to drive the growth of the bilirubin blood test market in the coming years. Liver diseases encompass a variety of conditions that hinder normal liver function and may arise from causes such as infections, excessive alcohol intake, or metabolic disorders. The rise in liver disease cases is largely linked to growing obesity rates, high alcohol consumption, viral infections, and unhealthy lifestyle habits, all of which contribute to liver damage and dysfunction. Liver disease can markedly affect bilirubin levels in the body, and bilirubin blood tests are used to diagnose and monitor liver function, offering essential information about patient health while supporting healthcare professionals in the effective management and treatment of liver-related conditions. For instance, in April 2023, according to GOV.UK, a UK-based department for science, innovation, and technology, hospital admission rates for liver disease rose from 150.6 (148.2-152.9) to 155.2 (152.9-157.5) per 100,000 population between the financial years ending 2022 and 2023, highlighting a sustained upward trend in liver disease-related hospitalizations. Therefore, the growing incidence of liver diseases is driving the growth of the bilirubin blood test market.

Leading companies in the bilirubin blood test market are increasingly forming strategic partnerships to broaden their reach and improve their offerings. A strategic partnership involves a collaborative relationship between organizations that combines resources and expertise to achieve mutual goals. For example, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology firm, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia for its bilirubin test for newborns. Techno Orbits will manage the distribution and sales of Calmark's product, utilizing its established network and connections, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark's bilirubin test into the Saudi market, with regulatory registration expected to take between 3 to 6 months.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition is designed to bolster Mindray's competitive position in the in vitro diagnostic (IVD) sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. The acquisition is expected to enhance Mindray's capabilities in serving medium- to large-volume customers and improve service delivery. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in diagnostic systems, including bilirubin blood tests for liver diseases.

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMerieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bilirubin blood test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bilirubin blood test market consists of sales of products such as diagnostic devices for measuring bilirubin levels, including test kits, blood analyzers, and automated testing systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bilirubin Blood Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bilirubin blood test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bilirubin blood test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bilirubin blood test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Total Serum Bilirubin Test; Indirect Or Unconjugated Bilirubin Test; Direct Or Conjugated Bilirubin Test
  • 2) By Age Group: Adults; Pediatrics; Infants
  • 3) By Application: Hospital; Clinic; Other Applications
  • Subsegments:
  • 1) By Total Serum Bilirubin Test: Routine Screening; Liver Function Assessment; Newborn Jaundice Detection
  • 2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis; Gilbert's Syndrome Detection; Monitoring For Preliver Conditions
  • 3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis; Hepatitis And Liver Disease Monitoring; Post-Liver Condition Assessment
  • Companies Mentioned: Abbott Laboratories; Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Siemens Healthineers; Danaher Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc; Ortho Clinical Diagnostics Inc; Mindray Medical International Limited; Randox Laboratories Ltd; bioMerieux SA; DiaSorin S.p.A; Horiba Ltd; ELITech Group SAS; Erba Mannheim; Hitachi High-Technologies; DIRUI Industrial Co Ltd; Agappe Diagnostics; Awareness Technology Inc; Sekisui Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Bilirubin Blood Test Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Bilirubin Blood Test Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Bilirubin Blood Test Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Bilirubin Blood Test Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Bilirubin Testing For Liver Function Assessment
    • 4.2.2 Growing Adoption Of Bilirubin Tests In Neonatal Jaundice Screening
    • 4.2.3 Rising Testing Demand In Hematology And Preliver Disorder Evaluation
    • 4.2.4 Expansion Of Bilirubin Monitoring Across Hospital And Clinical Settings
    • 4.2.5 Focus On Early Detection And Routine Screening For Liver Health

5. Bilirubin Blood Test Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Laboratories
  • 5.4 Pediatric And Neonatal Care Centers
  • 5.5 Specialty Liver And Gastroenterology Centers

6. Bilirubin Blood Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bilirubin Blood Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Bilirubin Blood Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Bilirubin Blood Test Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Bilirubin Blood Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Bilirubin Blood Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bilirubin Blood Test Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bilirubin Blood Test Market Segmentation

  • 9.1. Global Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
  • 9.2. Global Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adults, Pediatrics, Infants
  • 9.3. Global Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Clinic, Other Applications
  • 9.4. Global Bilirubin Blood Test Market, Sub-Segmentation Of Total Serum Bilirubin Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Routine Screening, Liver Function Assessment, Newborn Jaundice Detection
  • 9.5. Global Bilirubin Blood Test Market, Sub-Segmentation Of Indirect Or Unconjugated Bilirubin Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hemolytic Anemia Diagnosis, Gilbert's Syndrome Detection, Monitoring For Preliver Conditions
  • 9.6. Global Bilirubin Blood Test Market, Sub-Segmentation Of Direct Or Conjugated Bilirubin Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

10. Bilirubin Blood Test Market Regional And Country Analysis

  • 10.1. Global Bilirubin Blood Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Bilirubin Blood Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bilirubin Blood Test Market

  • 11.1. Asia-Pacific Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bilirubin Blood Test Market

  • 12.1. China Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bilirubin Blood Test Market

  • 13.1. India Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bilirubin Blood Test Market

  • 14.1. Japan Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bilirubin Blood Test Market

  • 15.1. Australia Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bilirubin Blood Test Market

  • 16.1. Indonesia Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bilirubin Blood Test Market

  • 17.1. South Korea Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bilirubin Blood Test Market

  • 18.1. Taiwan Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bilirubin Blood Test Market

  • 19.1. South East Asia Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bilirubin Blood Test Market

  • 20.1. Western Europe Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bilirubin Blood Test Market

  • 21.1. UK Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bilirubin Blood Test Market

  • 22.1. Germany Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bilirubin Blood Test Market

  • 23.1. France Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bilirubin Blood Test Market

  • 24.1. Italy Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bilirubin Blood Test Market

  • 25.1. Spain Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bilirubin Blood Test Market

  • 26.1. Eastern Europe Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bilirubin Blood Test Market

  • 27.1. Russia Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bilirubin Blood Test Market

  • 28.1. North America Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bilirubin Blood Test Market

  • 29.1. USA Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bilirubin Blood Test Market

  • 30.1. Canada Bilirubin Blood Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bilirubin Blood Test Market

  • 31.1. South America Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bilirubin Blood Test Market

  • 32.1. Brazil Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bilirubin Blood Test Market

  • 33.1. Middle East Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bilirubin Blood Test Market

  • 34.1. Africa Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Bilirubin Blood Test Market, Segmentation By Test Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bilirubin Blood Test Market Regulatory and Investment Landscape

36. Bilirubin Blood Test Market Competitive Landscape And Company Profiles

  • 36.1. Bilirubin Blood Test Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Bilirubin Blood Test Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Bilirubin Blood Test Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Bilirubin Blood Test Market Other Major And Innovative Companies

  • Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMerieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

38. Global Bilirubin Blood Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bilirubin Blood Test Market

40. Bilirubin Blood Test Market High Potential Countries, Segments and Strategies

  • 40.1 Bilirubin Blood Test Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Bilirubin Blood Test Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Bilirubin Blood Test Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer